Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,045 | -17,465 | -7,348 | 2,779 | 3,017 |
| Accounts payable and accrued liabilities | 2,474 | 1,043 | -537 | -6,106 | -6,268 |
| Other Working Capital | 9,554 | 8,227 | 2,176 | -11,730 | -8,167 |
| Other Operating Activity | -1,820 | -585 | 783 | -12,126 | -7,049 |
| Operating Cash Flow | $-18,837 | $-8,781 | $-4,927 | $-27,182 | $-18,467 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -1 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-1 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,945 | N/A | N/A | 27,876 | 27,406 |
| Financing Cash Flow | $20,945 | $N/A | $N/A | $27,876 | $27,406 |
| Beginning Cash Position | 13,291 | 13,291 | 13,291 | 12,598 | 12,598 |
| End Cash Position | 15,399 | 4,510 | 8,364 | 13,291 | 21,537 |
| Net Cash Flow | $2,108 | $-8,781 | $-4,927 | $693 | $8,939 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,837 | -8,781 | -4,927 | -27,182 | -18,467 |
| Free Cash Flow | -18,837 | -8,781 | -4,927 | -27,182 | -18,467 |